Nutlin-3a as a novel anticancer agent for adrenocortical carcinoma with CTNNB1 mutation.

about

Nutlin-3a as a novel anticancer agent for adrenocortical carcinoma with CTNNB1 mutation.

Item

http://www.wikidata.org/entity/Q52658500

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Nutlin-3a as a novel anticancer agent for adrenocortical carcinoma with CTNNB1 mutation.

@en

Nutlin-3a as a novel anticancer agent for adrenocortical carcinoma with CTNNB1 mutation.

@nl

type

Item

label

Nutlin-3a as a novel anticancer agent for adrenocortical carcinoma with CTNNB1 mutation.

@en

Nutlin-3a as a novel anticancer agent for adrenocortical carcinoma with CTNNB1 mutation.

@nl

prefLabel

Nutlin-3a as a novel anticancer agent for adrenocortical carcinoma with CTNNB1 mutation.

@en

Nutlin-3a as a novel anticancer agent for adrenocortical carcinoma with CTNNB1 mutation.

@nl

P1476

Nutlin-3a as a novel anticancer agent for adrenocortical carcinoma with CTNNB1 mutation.

@en

P2093

Chenchen Feng

http://www.w3.org/2001/XMLSchema#string

Jie Zheng

http://www.w3.org/2001/XMLSchema#string

Qiang Ding

http://www.w3.org/2001/XMLSchema#string

Wen Hui

http://www.w3.org/2001/XMLSchema#string

Zujun Fang

http://www.w3.org/2001/XMLSchema#string

P2860

A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers

Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment

The challenge of developmental therapeutics for adrenocortical carcinoma

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

p53 and microRNA-34 are suppressors of canonical Wnt signaling.

Wnt/β-catenin signaling regulates the proliferation and differentiation of mesenchymal progenitor cells through the p53 pathway

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center

Pregnancy, Primary Aldosteronism, and Adrenal CTNNB1 Mutations.

P304

1440-1449

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CAM4.1431

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Shenghua Liu

P577

2018-03-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29532999

http://www.w3.org/2001/XMLSchema#string

P932

5911589

http://www.w3.org/2001/XMLSchema#string